Patent US4010148A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4010148A Expired / Lapsed US ⏱️ 0.0 years remaining

Purified thymosin and process

Assignee: The University of Texas System
•
Filing: 1975-05-12
•
Granted: 1977-03-01
•
Expires: 1995-05-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A highly purified extract of the mammalian thymus gland and a process for its preparation is described. This extract is a hormonally active proteinaceous material which is involved in the regulation of cell-mediated immunity. The hormone has been named thymosin.

Inventors

  • 👤 Allan Leonard Goldstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 21:34
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/57581; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/837

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 186 words
In a process for recovering a biologically active protein component from thymus tissue, said process comprising i. homogenizing and extracting thymic tissue in aqueous saline solution, then centrifuging to remove undissolved material; ii. heat treating the centrifuge supernatant at about 80° C., which treatment precipitates undesired fraction then centrifuging to remove the precipitated portions; iii. admixing the supernatant with a large excess of cold acetone, thereby precipitating the active fraction, and collecting said precipitate; iv. dissolving the acetone precipitate in phosphate buffer, then adding ammonium sulfate to about 25% of saturation and removing non-soluble impurity; and v. increasing the ammonium sulfate content to about 50% of saturation, thereby precipitating the active fraction; the improvement which comprises in combination A. dissolving the collected precipitate from step (v) in phosphate buffer and ultrafiltering the solution using a membrane having a molecular weight cut-off of 15,000; B. concentrating the ultrafiltration filtrate and treating the residue by column chromatography to thereby separate salt and nucleotides; C. isolating the protein peak from (B) and then additionally purifying the protein material by column chromatography followed by gel filtration and then gel electrophoresis.
Claim 2
Dependent Claim 186 words
In a process for recovering a biologically active protein component from thymus tissue, said process comprising i. homogenizing and extracting thymic tissue in aqueous saline solution, then centrifuging to remove undissolved material; ii. heat treating the centrifuge supernatant at about 80° C., which treatment precipitates undesired fraction then centrifuging to remove the precipitated portions; iii. admixing the supernatant with a large excess of cold acetone, thereby precipitating the active fraction, and collecting said precipitate; iv. dissolving the acetone precipitate in phosphate buffer, then adding ammonium sulfate to about 25% of saturation and removing non-soluble impurity; and v. increasing the ammonium sulfate content to about 50% of saturation, thereby precipitating the active fraction; the improvement which comprises in combination A. dissolving the collected precipitate from step (v) in phosphate buffer and ultrafiltering the solution using a membrane having a molecular weight cut-off of 15,000; B. concentrating the ultrafiltration filtrate and treating the residue by column chromatography to thereby separate salt and nucleotides; C. isolating the protein peak from (B) and then additionally purifying the protein material by column chromatography followed by gel filtration and then gel electrophoresis.
Claim 3
Dependent Claim 15 words
The process of claim 1 wherein said ultrafiltration is conducted in a hollow fiber system.
Claim 4
Dependent Claim 17 words
The process of claim 1 wherein the column chromatography of step (B) is conducted on Sephadex G-25.
Claim 5
Dependent Claim 17 words
The process of claim 1 wherein the gel filtration of step (C) is conducted on Sephadex G-50.
Claim 6
Dependent Claim 19 words
The process of claim 1 wherein the gel electrophoresis is conducted on 15% polyacrylamide gel using pH 8.3 buffer.
Claim 7
Dependent Claim 96 words
The process of claim 1 wherein bovine thymus tissue is employed and the protein component isolated is essentially free of carbohydrate, lipid, nucleotide and cyclic AMP, is homogeneous on 15% polyacrylamide gel electrophoresis at pH 8.3 and 2.9, has a molecular weight of about 12,200 and an amino acid composition as follows: ______________________________________ Amino acid Residues/molecules ______________________________________ Lysine 4 Histidine 1 Arginine 2 Aspartic acid 22 Threonine 4 Serine 5 Glutamic acid 32 Proline 5 Glycine 6 Alanine 7 Cysteine 1 Valine 5 Methionine 2 Isoleucine 3 Leucine 6 Tyrosine 1 Phenylalanine 2 Total 108 ______________________________________
Claim 8
Dependent Claim 48 words
An improved process for preparing thymosin fraction 5 which process comprises ultrafiltering a solution of thymosin fraction 4 in phosphate buffer using a membrane having a molecular weight cut-off of 15,000 concentrating the ultrafiltration filtrate and treating the residue by column chromatography to thereby separate salt and nucleotide.
Claim 9
Dependent Claim 48 words
An improved process for preparing thymosin fraction 5 which process comprises ultrafiltering a solution of thymosin fraction 4 in phosphate buffer using a membrane having a molecular weight cut-off of 15,000 concentrating the ultrafiltration filtrate and treating the residue by column chromatography to thereby separate salt and nucleotide.
Claim 10
Dependent Claim 15 words
The process of claim 7 wherein said ultrafiltration is conducted in a hollow fiber system.
Claim 11
Dependent Claim 14 words
The process of claim 7 wherein said column chromatography is conducted on Sephdex G-25.

References Cited (Backward Citations)

FR7373E Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-02-29 1980-08-30 1981-03-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-02-29 1984-08-30 1985-03-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-02-29 1988-08-30 1989-03-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag